Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease Clinical Trial

Official title: A 24-Week, Open-Label, Randomized, 2-Arm Study to Evaluate the Safety and Tolerability of KRX-0502 (Ferric Citrate) in Children With Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease

Status Not yet recruiting

Clinical Trial Summary

This study will be conducted to evaluate the safety and tolerability of ferric citrate in pediatric participants with iron deficiency anemia (IDA) associated with non-dialysis dependent chronic kidney disease (NDD-CKD).

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Anemia
• Anemia, Iron-Deficiency
• Deficiency Diseases
• Iron Deficiency Anemia Associated With Non-Dialysis Dependent Chronic Kidney Disease
• Kidney Diseases
• Renal Insufficiency, Chronic

• NCT number: NCT04649411
• Study type: Interventional
• Source: Keryx Biopharmaceuticals
• Contact: Akebia Medical Information
• Phone: 844-445-3799
• Email: medicalinfo@akebia.com
• Status: Not yet recruiting
• Phase: Phase 3
• Start date: January 2025
• Completion date: March 2027